EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hermetia illucens chitosan: indirect and direct antimicrobial activity of an innovative biopolymer for clinical and pharmaceutical applications

Guarnieri Anna, Fusco Alessandra, Scieuzo Carmen, Salvia Rosanna, Donnarumma Giovanna, Falabella Patrizia

Applied Microbiology and Biotechnology · 2025

DOI: 10.1007/s00253-025-13643-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2025. Verfasst von Guarnieri Anna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Applied Sciences, University of Basilicata, Via Dell'Ateneo Lucano 10, 85100, Potenza, Italy. Hauptthemen laut MEDLINE: Chitosan, Anti-Bacterial Agents, Anti-Infective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Università degli Studi della Basilicata.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing spread of antimicrobial resistance has prompted the search for innovative alternatives to conventional antibiotics. Chitosan, a biopolymer derived from chitin, is known for its broad-spectrum antimicrobial activity. This study evaluated both direct and indirect antimicrobial activity of chitosan obtained from Hermetia illucens , a novel and sustainable source compared to the traditionally crustacean-derived biopolymer. Chitosan produced from H. illucens larvae, pupal exuviae and adults, through heterogeneous and homogeneous deacetylation, was tested for both its indirect and direct antimicrobial effects. The indirect effect was evaluated by measuring the induction of Human Beta-Defensin-2 ( HBD-2 ) expression in HaCaT keratinocytes stimulated with lipopolysaccharide of Salmonella typhimurium , a Gram-negative bacterium. The direct antimicrobial activity was assessed against Gram-positive pathogens ( Enterococcus faecalis , Staphylococcus epidermidis , and Streptococcus agalactiae ), using a microdilution assay and plate colony count. Results demonstrated significant bacteriostatic effects at 0.5 mg/mL, with some samples, particularly the homogeneous unbleached pupal exuviae chitosan and the heterogeneous unbleached larvae chitosan, comparable to or even superior to commercial chitosan in terms of biological activity. Furthermore, insect-chitosan significantly up-regulated HBD-2 expression, suggesting immunomodulatory activity. These findings validated H. illucens as a promising alternative source of chitosan with dual antimicrobial activity, and supported its potential use in clinical, pharmaceutical and biomedical applications. Key points • Insect-chitosan activates innate immunity via strong HBD-2 induction • Chitosan samples showed notable growth-inhibition toward key Gram-positive strains • Hermetia illucens chitosans provide efficacy comparable or superior to the commercial biopolymer

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanAnti-Bacterial AgentsAnti-Infective AgentsHumansAnimalsMicrobial Sensitivity TestsLarvabeta-DefensinsGram-Positive BacteriaBiopolymersKeratinocytesHaCaT Cells

Stichwörter der Autor:innen

Hermetia illucensChitosanIndirect and direct antimicrobial activityPharmaceutical field

Substanzen

Chitosanbeta-DefensinsDEFB4A protein, humanAnti-Bacterial AgentsBiopolymersAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Basic and Applied Sciences, University of Basilicata, Via Dell'Ateneo Lucano 10, 85100, Potenza, Italy.
  • Department of Life Sciences, Health and Health Professions, Link Campus University, 00165, Rome, Italy.
  • Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy.
  • Spinoff XFlies S.R.L, University of Basilicata, Via Dell'Ateneo Lucano 10, 85100, Potenza, Italy.
  • Department of Basic and Applied Sciences, University of Basilicata, Via Dell'Ateneo Lucano 10, 85100, Potenza, Italy. patrizia.falabella@unibas.it.
  • Spinoff XFlies S.R.L, University of Basilicata, Via Dell'Ateneo Lucano 10, 85100, Potenza, Italy. patrizia.falabella@unibas.it.

Förderung

  • Ministero dell'Università e della Ricerca
  • Università degli Studi della Basilicata

Zitieren

APA

Anna, G., Alessandra, F., Carmen, S., Rosanna, S., Giovanna, D., & Patrizia, F. (2025). Hermetia illucens chitosan: indirect and direct antimicrobial activity of an innovative biopolymer for clinical and pharmaceutical applications. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-025-13643-7

Vancouver

Anna G, Alessandra F, Carmen S, Rosanna S, Giovanna D, Patrizia F. Hermetia illucens chitosan: indirect and direct antimicrobial activity of an innovative biopolymer for clinical and pharmaceutical applications. Applied Microbiology and Biotechnology. 2025. doi:10.1007/s00253-025-13643-7

BibTeX
@article{Anna2025,
  author = {Anna, Guarnieri and Alessandra, Fusco and Carmen, Scieuzo and Rosanna, Salvia and Giovanna, Donnarumma and Patrizia, Falabella},
  title = {Hermetia illucens chitosan: indirect and direct antimicrobial activity of an innovative biopolymer for clinical and pharmaceutical applications},
  journal = {Applied Microbiology and Biotechnology},
  year = {2025},
  doi = {10.1007/s00253-025-13643-7}
}
Kostenlos starten →